Emedastine

A histamine H1 receptor antagonist.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Emedastine is a second generation histamine H1 receptor antagonist. It is used for the management of allergy (NCIt).

Emedastine on DrugBank
Emedastine on PubChem
Emedastine on Wikipedia


Marketed as

EMADINE (EMEDASTINE DIFUMARATE)

 

Structure image - Emedastine

CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C


Supporting references

Link Tested on Impact factor Notes Publication date
Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2
Small molecule Enzyme assay Screening
in vitro 6.71

Inhibits SARS-CoV-2 3C-like protease in vitro.

Jul/28/2020